New double-drug therapy gives fresh hope to Brits with oesophagus cancer
>A double-drug therapy offers the best hope yet for thousands of Britons with cancer of the oesophagus.New trial results suggest that patients given the immunotherapy medicine tislelizumab alongside chemotherapy are likely to live much…